Key result
Severe subclinical pulmonary edema post-STEMI without heart failure is linked to ~112% higher in-hospital major cardiovascular events risk.
Why the study?
Subclinical pulmonary edema after acute STEMI without heart failure has not received sufficient clinical attention, leaving its prognostic value and clinical characteristics unclear.
Does subclinical pulmonary edema detected by chest CT predict major adverse cardiovascular events in patients with acute STEMI without heart failure?
Cohort (n=276)
No
Does subclinical pulmonary edema detected by chest CT predict major adverse cardiovascular events in patients with acute STEMI without heart failure?
Subclinical pulmonary edema detected by chest CT in acute STEMI patients without clinical heart failure provides crucial prognostic information and is associated with a 2.12-fold increased risk of in-hospital MACEs.
Answers are grounded in this paper and cite their sources.
May aid in-hospital risk stratification after STEMI without HF; leaves open whether CT screening should guide therapy.
BACKGROUND Pulmonary edema is a severe complication in patients with acute myocardial infarction which indicates the development of heart failure (HF) and poor prognosis. However, subclinical pulmonary edema after acute ST-segment elevation myocardial infarction (STEMI) without HF has not received enough attention in clinical practice. We aimed to investigate the prognostic value and associated clinical characteristics of subclinical pulmonary edema after acute STEMI without HF detected by chest computed tomography (CT). METHODS A total of 276 patients with acute STEMI without HF who underwent chest CT were included in this study. K-means clustering analysis was performed to classify the patients into different subgroups based on the mean lung density. Clinical characteristics of the different subgroups were compared and used to establish a machine learning model for discriminating between them. Relative risk (RR) for major adverse cardiovascular events (MACEs) during hospitalization was compared between the subgroups. RESULTS The patients were classified into two subgroups. Subgroup 2 showed higher mean lung density than subgroup 1 (median [IQR], −727 [−747, −704] vs. −806 [−826, −785] HU, P < 0.001), with significantly higher levels of cardiac enzymes and numbers of inflammatory cells and significantly worse left ventricular function than subgroup 1. In the model analysis, the most important clinical characteristics were the levels of cardiac enzymes, numbers of inflammatory cells, and left ventricular function. The risk for MACEs was higher in subgroup 2 than in subgroup 1 (RR, 2.12; P = 0.002). CONCLUSIONS Subclinical pulmonary edema after acute STEMI without HF was mainly associated with elevated levels of cardiac enzymes, followed by increased numbers of inflammatory cells and worse left ventricular function. In addition, subclinical pulmonary edema provided crucial prognostic information for patients during hospitalization.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2023) conducted a cohort in Acute ST-segment elevation myocardial infarction (STEMI) without heart failure (n=276). Severe subclinical pulmonary edema (Subgroup 2) vs. Mild subclinical pulmonary edema (Subgroup 1) was evaluated on Major adverse cardiovascular events (MACEs) during hospitalization (RR 2.12, p=0.002). Severe subclinical pulmonary edema after acute STEMI without heart failure was associated with a higher risk of major adverse cardiovascular events during hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: